The landmark discovery of the VHL tumor-suppressor gene and the observation that VHL is mutated in up to 90% of patients with ccRCC has helped elucidate the molecular interplay in the RCC tumor microenvironment [78]. The gene discussed is VHL; the disease is renal cell carcinoma.